C21 Investments Inc. (CXXI)
CSE
Closed
Aug 21, 2026
Day's Range
0.385052 wk Range
0.2650Overview - CXXI - C21 Investments Inc.
Key Statistics
Valuation
Enterprise Value
74.28M
P/E (Trailing)
‪36.50‬
Price / Sales (TTM)
‪1.40‬
Price / Book
‪1.28‬
EV / EBITDA
‪15.06‬
Profitability
Gross Margin
‪43.51%‬
Profit Margin
‪-9.94%‬
Operating Margin
‪6.58%‬
Return on Assets
‪2.57%‬
Return on Equity
‪-11.96%‬
Ownership
Shares Outstanding
117.83M
Float
104.34M
Short % of Shares Outstanding
‪0.09%‬
Held by Insiders
‪12.32%‬
Held by Institutions
‪5.50%‬
Price stats
Beta
‪1.87‬
50-Day Avg
‪0.3383‬
200-Day Avg
‪0.3987‬
Dividends
Payout Ratio
‪0.00%‬
Peers - CXXI - C21 Investments Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on CSE.
Profile Summary - CXXI - C21 Investments Inc.
About
C21 Investments Inc. is a company engaged in the production and distribution of cannabis and hemp-derived consumer products. Its primary focus lies in cultivating and processing high-quality cannabis products for medical and recreational use. The company has established a presence in several U.S. states, including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
